Matching slides 96,741
Current window 75,841-75,870
Pages 3,225
Rows per page 30
Component: Calloutclear collectionreset all

Component

75,841-75,870 of 96,741

filter-aware
116
Contains highlighted text segments within the quotes.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
117
The slide uses a Q&A format to highlight a specific allegation of regulatory non-compliance.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
118
The slide uses red circles and arrows to annotate screenshots of the CMS Open Payments database to point out irregularities.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
119
The slide uses a Q&A format to build a case of corporate malfeasance or regulatory avoidance.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
120
The slide uses a quote to expose potential unethical vendor practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
122
The slide uses a Q&A transcript format to substantiate claims of industry-wide corruption and ongoing investigations.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
123
The slide uses a Q&A transcript format to substantiate claims of kickbacks in the organ transport industry.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
124
This slide serves as a transition or section header for a highly critical argument against the company.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
125
The slide uses a legal statute to frame the company's business model as criminal activity.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
127
The slide uses a combination of narrative summary and direct excerpts from a Feb 2024 letter to expose flaws in the OPTN allocation system.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
129
The slide uses a direct quote from a transplant surgeon to allege systemic gaming of the organ allocation system.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
131
The slide uses a Q&A transcript format to highlight a competitor's critique of the subject company's business model.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
132
The slide uses a 'villain' narrative framing, comparing the medical system to a cartel and highlighting the 'addiction to volume' as a driver for TransMedics service adoption.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
133
The slide presents a narrative of systemic corruption and regulatory bypass involving TransMedics and OPOs.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
134
The slide uses a Q&A format to document expert testimony regarding potential kickbacks and regulatory circumvention.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
135
The slide uses a Q&A format to highlight alleged unethical business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
137
The slide uses a Q&A format to highlight a specific allegation of unethical business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
138
The slide presents a Q&A format with a surgeon, highlighting allegations of unethical business practices and operational friction.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
139
The slide uses a Q&A format to present testimonial evidence of alleged misconduct.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
140
The slide uses a Q&A format to provide direct evidence of unethical behavior in the organ transplant system.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
141
The slide uses a Q&A format to highlight alleged procedural violations. The yellow highlighting emphasizes the specific claims of bypassing the OPO.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
142
Includes a Q&A transcript excerpt highlighting potential ethical/regulatory concerns regarding organ allocation and communication methods.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
143
The slide uses a 'smoking gun' narrative to frame the testimonial as evidence of unethical business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
144
Includes a Q&A transcript excerpt as evidence for the allegations.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
145
The slide uses a Q&A format to present testimony from an industry veteran, highlighting allegations of unethical sales practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
146
The slide uses a Q&A format to highlight potential regulatory violations by TransMedics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
147
The slide uses a combination of summary text and a direct quote from a high-volume user to substantiate the claim of unethical organ allocation practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
149
The slide uses screenshots of the UNOS/UNet portal to establish the system's official status and legal warnings.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
150
The slide uses a Q&A transcript format to highlight potential ethical concerns regarding vendor access to sensitive medical data.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
151
The slide presents two Q&A excerpts from a transplant surgeon to support the claim that TransMedics is hijacking the organ allocation process.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit